Fear of Cancer Recurrence and Associated Factors in Lymphoma Survivors and Their Family Caregivers: A Cross-Sectional Study.

Taha Koray Sahin, Ezgi Aysu Sahin, Hande Nur Gungor, Deniz Can Guven, Ibrahim Barista, Serkan Akin
Author Information
  1. Taha Koray Sahin: Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey. ORCID
  2. Ezgi Aysu Sahin: Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  3. Hande Nur Gungor: Department of Internal Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  4. Deniz Can Guven: Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey. ORCID
  5. Ibrahim Barista: Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
  6. Serkan Akin: Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.

Abstract

BACKGROUND: Fear of cancer recurrence (FCR) is a pervasive concern among lymphoma survivors and their family caregivers, influencing psychological and physical health. Given the substantial burden of FCR, identifying its predictors is crucial for targeted interventions that could enhance palliative care. We aimed to evaluate the prevalence of FCR in lymphoma survivors and their caregivers, as well as associated factors METHODS: A total of 118 patients with lymphoma, along with their family caregivers, were recruited from Hacettepe University Cancer Institute between March 2024 and May 2024. Psychological assessments were conducted using the Depression Anxiety Stress Scales (DASS-21), the Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF) and the Functional Assessment of Cancer Therapy-Lymphoma (FACT-Lym) RESULTS: High levels of FCR were experienced by 50.8% (n = 60) of lymphoma survivors and 57.6% (n = 68) of their caregivers. There was a positive correlation between the FCR of the survivors and caregivers (r = 0.349, p < 0.001). Poor overall quality of life (QoL) (aOR: 4.279, 95% CI: 1.738-10.531, p = 0.002), recent diagnosis (< 3 year) (aOR: 5.135, 95% CI: 1.852-14.238, p = 0.002), survivors' anxiety (aOR: 2.540, 95% CI: 1.014-6.363, p = 0.002) and caregivers' FCR (aOR: 2.970, 95% CI: 1.119-7.879, p = 0.029) were associated with high levels of FCR in lymphoma survivors.
CONCLUSION: We observed high FCR levels in over half the survivors with lymphoma and a higher FCR risk in patients with anxiety, poor QoL and caregiver FCR. These findings highlight the critical need for developing comprehensive care plans and interventions targeting FCR in patients with lymphoma.

Keywords

References

  1. Blood. 2022 Sep 15;140(11):1229-1253 [PMID: 35653592]
  2. Psychooncology. 2023 Aug;32(8):1173-1191 [PMID: 37303263]
  3. J Cancer Surviv. 2025 Feb;19(1):1-11 [PMID: 37610477]
  4. Psychol Health Med. 2019 Aug;24(7):781-787 [PMID: 30714815]
  5. J Cancer Surviv. 2022 Dec;16(6):1184-1219 [PMID: 34762248]
  6. Psychooncology. 2009 Jun;18(6):580-8 [PMID: 18855944]
  7. Br J Haematol. 2019 Nov;187(4):478-487 [PMID: 31385291]
  8. CA Cancer J Clin. 2022 Sep;72(5):409-436 [PMID: 35736631]
  9. Psychooncology. 2021 Oct;30(10):1765-1772 [PMID: 33982371]
  10. Cancers (Basel). 2024 Feb 23;16(5): [PMID: 38473270]
  11. Psychooncology. 2022 Jun;31(6):879-892 [PMID: 35388525]
  12. J Psychosoc Oncol. 2020 May-Jun;38(3):251-271 [PMID: 31617830]
  13. Behav Res Ther. 1995 Mar;33(3):335-43 [PMID: 7726811]
  14. Front Oncol. 2022 Sep 27;12:942122 [PMID: 36237337]
  15. Support Care Cancer. 2020 Dec;28(12):5973-5982 [PMID: 32285261]
  16. Nurs Res. 2017 Jul/Aug;66(4):295-303 [PMID: 28654567]
  17. Curr Opin Support Palliat Care. 2019 Sep;13(3):238-242 [PMID: 31157656]
  18. Cancer. 2024 Aug 15;130(16):2739-2742 [PMID: 38630904]
  19. Psychooncology. 2020 Feb;29(2):364-372 [PMID: 31654534]
  20. Psychooncology. 2017 Jan;26(1):22-28 [PMID: 26490953]
  21. Acta Oncol. 2019 May;58(5):708-714 [PMID: 30741082]
  22. Semin Oncol Nurs. 2019 Aug;35(4):337-341 [PMID: 31248677]
  23. J Cancer Surviv. 2015 Sep;9(3):481-91 [PMID: 25603948]
  24. Psychooncology. 2016 Jul;25(7):772-8 [PMID: 26464337]
  25. Ann Oncol. 2011 Apr;22(4):761-772 [PMID: 20870912]
  26. Semin Hematol. 2023 Nov;60(5):277-284 [PMID: 38072721]
  27. JAMA Netw Open. 2024 Jan 2;7(1):e2351062 [PMID: 38241048]
  28. Psychooncology. 2007 Mar;16(3):214-23 [PMID: 16906624]
  29. J Cancer Surviv. 2013 Sep;7(3):300-22 [PMID: 23475398]
  30. Florence Nightingale J Nurs. 2020 Jul 03;28(2):143-154 [PMID: 34263193]
  31. Psychol Res Behav Manag. 2020 Dec 21;13:1257-1268 [PMID: 33376421]
  32. Psychooncology. 2017 Oct;26(10):1444-1454 [PMID: 27246348]
  33. J Cancer Surviv. 2024 Jan 4;: [PMID: 38175366]
  34. Bone Marrow Transplant. 2014 Sep;49(9):1217-22 [PMID: 25000458]
  35. Ann Surg Oncol. 2012 Dec;19(13):4078-84 [PMID: 22875648]
  36. Psychooncology. 2021 Aug;30(8):1185-1195 [PMID: 33880822]
  37. Psychooncology. 2007 Oct;16(10):895-903 [PMID: 17245695]
  38. Psychooncology. 2012 Jun;21(6):571-87 [PMID: 22021099]
  39. Support Care Cancer. 2009 Mar;17(3):241-51 [PMID: 18414902]
  40. Psychooncology. 2013 Apr;22(4):807-13 [PMID: 22451036]
  41. Front Digit Health. 2023 Aug 21;5:1129536 [PMID: 37671170]
  42. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-10 [PMID: 35561298]

MeSH Term

Humans
Male
Female
Caregivers
Cancer Survivors
Cross-Sectional Studies
Lymphoma
Middle Aged
Fear
Adult
Quality of Life
Neoplasm Recurrence, Local
Aged
Anxiety

Word Cloud

Created with Highcharts 10.0.0FCRlymphomasurvivorscaregiversCanceraOR:95%CI:1p = 0Fearcancerpatientslevels002anxietyrecurrencefamilyinterventionscareassociated2024RecurrencequalitylifeQoL2highcaregiverBACKGROUND:pervasiveconcernamonginfluencingpsychologicalphysicalhealthGivensubstantialburdenidentifyingpredictorscrucialtargetedenhancepalliativeaimedevaluateprevalencewellfactorsMETHODS:total118alongrecruitedHacettepeUniversityInstituteMarchMayPsychologicalassessmentsconductedusingDepressionAnxietyStressScalesDASS-21Inventory-ShortFormFCRI-SFFunctionalAssessmentTherapy-LymphomaFACT-LymRESULTS:Highexperienced508%n = 60576%n = 68positivecorrelationr = 0349p < 0001Pooroverall4279738-10531recentdiagnosis< 3 year5135852-14238survivors'540014-6363caregivers'970119-7879029CONCLUSION:observedhalfhigherriskpoorfindingshighlightcriticalneeddevelopingcomprehensiveplanstargetingAssociatedFactorsLymphomaSurvivorsFamilyCaregivers:Cross-SectionalStudyfearoncology

Similar Articles

Cited By

No available data.